Mark Kowalski

Insider Reports History

Entity
Individual
Location
C/O Arbutus Biopharma Corp., 100 8900 Glenlyon Parkway, Burnaby, British Columbia, Canada
Signature
/s/ Mark M. Kowalski / By: Mary Christina Thomson, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Kowalski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sierra Oncology, Inc. Chief, Research & Early Dev Stock Option (Right to Buy) 12.3K Jan 28, 2022 Direct

Insider Reports Filed by Mark Kowalski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRRA Sierra Oncology, Inc. Jan 28, 2022 1 $0 4 Jan 28, 2022 Chief, Research & Early Dev